The Leading Company in the World, PolarisAIPharma Co., Ltd.!

We have been devoting to all our energies to the development
of new active pharmaceutical ingredient

PolarisAIPharmaAbout us

History

  • HOME
  • PolarisAIPharma
  • History
2018
  • 03월 Acquired Russian GMP certificate of Baran plant by Russian Ministry of Health of the Russian Federation
2017
  • 06월 Passed site inspection by Japanese Ministry of Health, Labour and Welfare Olmesartan Medoxomil(Anti-Hypertensive)
    Renewed Accreditation of Foreign Manufacturers(AFM) of Baran plant by Japanese Ministry of Health, Labour and Welfare
2016
  • 03월 KOSHA 18001 certification (2016.03.12~2019.03.11)
2015
  • 04월 OHSAS 18001: 2007 (2015.04.10~2018.04.09)
    ISO14001: 2004 (2015.04.10~2018.04.09)
2013
  • 07월 Established R&D center in Beijing, China
2012
  • 05월 Received Order of Industrial Service Merit - Silver Tower
2011
  • 12월 Received $30M Export Tower Prize received by Korea International Trade Association
  • 10월 Appointed as a 'Hidden champion company' by Korea Eximbank
2010
  • 07월 Registered patent for Pranlukast (Anti-Asthmatic) in Japan
  • 03월 OHSAS 18001 certification
    KOSHA 18001 certification